Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 7 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

6Total
Not Applicable (4)
P 2 (2)

Trial Status

Recruiting4
Unknown2
Not Yet Recruiting1

Clinical Trials (7)

Showing 7 of 7 trials
NCT06790082Phase 2Recruiting

The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma

NCT05034146Not ApplicableRecruitingPrimary

68Ga-FAPI PET/CT in Malignant Tumors

NCT06911476Not Yet Recruiting

From Inflammation to Remodelling Towards Personalized Diagnosis in Post-acute Sequelae of COVID-19

NCT06604273Phase 2Recruiting

Unravelling Intestinal Fibrosis in Ulcerative Colitis

NCT06277180Not ApplicableRecruiting

68Ga-TCR-FAPI PET/CT Guided Precision Surgery for MTC

NCT06084767Not ApplicableUnknown

68Ga-TCR-FAPI PET/CT in Patients With Various Types of Cancer

NCT05339113Not ApplicableUnknown

Comparison of [68Ga]GaFAPI-46 PET/CT and [18F]FDG PET/CT Findings in Breast Carcinoma

Showing all 7 trials

Research Network

Activity Timeline